SDS
Sheehan Disability Scale

The Sheehan Disability Scale (SDS) is a short, simple, treatment outcome measure of disability and functional impairment.  It can be either patient-rated or clinician-rated.

Available versions: adult, adolescent, child.

S-STS
Sheehan – Suicidality Tracking Scale

The Sheehan – Suicidality Tracking Scale (S-STS) assesses all of the core suicidality phenomena. The Clinically Meaningful Change Measure (CMCM) version of the S-STS is designed for use as a primary outcome measure in clinical research studies investigating the efficacy of anti-suicidality medications. 

Available versions: adult, adolescent, child and adult and adolescent CMCM.

S-HTS
Sheehan – Homicidality Tracking Scale

The Sheehan – Homicidality Tracking Scale (S-HTS) assesses all of the core homicidality phenomena.  It can be used to assess and monitor these symptoms and behaviors over time.

Available versions: adult, adolescent, child and adult and adolescent CMCM.

S-CGI & S-PGI

The Sheehan – Global Improvement Scales are designed to provide an overall assessment of how much a patient’s symptoms and behaviors have improved or worsened since the start of treatment. The S-CGI and S-PGI are 21 point scales and was designed to provide more sensitivity than a 10 point global improvement scale in assessing global improvement.

MINI Tracking

The MINI Tracking is typically used to track change in symptom severity or change in a symptom cluster and monitor treatment response over time after an initial clinical interview using the MINI is conducted. A benefit of the MINI Tracking is that each of the tracking modules yields a score that can be plotted quantitatively on a graph.

MINI Kid Tracking

The MINI Kid Tracking is typically used to track change in symptom severity or change in a symptom cluster and monitor treatment response over time after an initial clinical interview using the MINI is conducted. A benefit of the MINI Tracking is that each of the tracking modules yields a score that can be plotted quantitatively on a graph.

SMS
Suicidality Modifiers Scale

The Suicidality Modifiers Scale (SMS) assesses factors that can influence key domains that can impact suicidality.  These factors include impulsive suicidality, hopelessness, loss of enjoyment, and overwhelmed feeling.

SPS
Sheehan Panic Disorder Scale

The Sheehan Panic Disorder Scale (SPS) assesses all of the core symptoms of Panic Disorder.  It can be used to assess and monitor these symptoms and behaviors over time.  It can be either patient-rated or clinician-rated.

S-SHSQ
Sheehan – Suicidality / Homicidality Screening Questions

The Sheehan – Suicidality / Homicidality Screening Questions (S-SHSQ) is a set of brief screening questions for suicidality and homicidality.  This is not a comprehensive suicidality or homicidality assessment and may be useful in primary care settings.

SIAS
Suicidal Impulse Attack Scale

The Suicidal Impulse Attack Scale (SIAS) assesses the components of a suicidal impulse attack. It is designed as a quick measure to monitor symptoms while a patient is experiencing a suicidal impulse attack.

Contact Dr. Sheehan

HMS
Homicidality Modifiers Scale

The Homicidality Modifiers Scale (HMS) assesses factors that can influence key domains that can impact homicidality.  These factors include impulsive homicidality, hopelessness, loss of enjoyment, and overwhelmed feeling.

HIAS
The Homicidal Impulse Attack Scale

The Homicidal Impulse Attack Scale (HIAS) assesses the components of a homicidal impulse attack. It is designed as a quick measure to monitor symptoms while a patient is experiencing a homicidal impulse attack.

SIS
Sheehan Irritability Scale

The Sheehan Irritability Scale (SIS) is a short self-report rating scale developed to measure the frequency, severity and impairment associated with irritability.

Training

Sheehan Scale FAQ

The Sheehan Scales can be used:

  • To assess and monitor the severity of specific symptoms (such as anxiety, irritability, suicidality), to monitor global improvement or to assess functional impairment over time and in response to treatment in primary care as well as mental health settings.
  • To identify and track specific symptoms or clusters of symptoms or impairment as an efficacy outcome measure, adverse event and/or treatment emergent effect in clinical trials and treatment outcome studies.
  • To detect and describe the incidence or prevalence and severity of such symptoms or impairment in population research including national and international epidemiology studies and community surveys.

Please CLICK HERE to be able to filter scales by disorder type, age group and type of research study. Use the filters on the left to make your selections.  When you have determined which scales you need, you can complete the relevant license agreement found on the page of the scale.

All of the Sheehan Scales can be patient-rated, clinician-rated, or rated by patient and clinician together at the same visit. Because of this flexibility they are useful for inpatients as well as outpatients and can also be used in community and population studies. However, to ensure safety and precision in research studies, we recommend training in the use of scales such as the S-STS and SDS. For more information about training CLICK HERE.

Yes. Many of Dr. Sheehan’s scales, most notably the Sheehan Disability Scale (SDS), the Sheehan-Suicidality Tracking Scale (S-STS), and Sheehan-Homicidality Tracking Scale (S-HTS) can be made available in pediatric and adolescent versions. Others can be customized for children and adolescents.

Yes, please CLICK HERE for watermarked preview copies only or contact Dr. Sheehan directly at davidVsheehan@gmail.com

Yes. Dr. Sheehan can design customized versions of most of his scales e.g. if you need a timeframe that is not an option for the version listed. Contact Dr. Sheehan at davidVsheehan@gmail.com to discuss a customized version designed for your needs.

A fully executed license and licensing fee applies to all uses. To license a Sheehan Scale for your use from Dr. Sheehan, you will need complete a license agreement. Links can be found on product pages to download a template license agreement for use. Then follow the instructions on the License Agreement form and once completed, please sign and send back to davidVsheehan@gmail.com

The cost of licensing one of the Sheehan Scales is $4 USD for each use/administration. Use/administration includes use in training/preparation activities and administration in a study.

Note: Non-profit institutions sometimes incorrectly assume that the license fee does not apply because they are “not-for-profit”. The licensing fee applies to all uses.

The license fee applies to all uses.

Most of the Sheehan scales have been validated. See individual listings of scales for specific information on validation.

Note: The Sheehan Scales are clinical decision support tools. They were tested for reliability and validity conditions in which they were rated in paper format as a primary source document. The results cannot be generalized to any other conditions or format.

A fully executed license is required for use of the Sheehan Disability Scale (SDS) in any language. To license the SDS directly from Dr. Sheehan, the author and copyright holder, you will need complete his license agreement. Click here to learn more about the SDS or to download a License for use.

Dr. Sheehan only provides consultation, guidance on regulatory agency questions, and training to those who license the SDS directly from him. Contact Dr. Sheehan at davidVsheehan@gmail.com for additional information. If you do not see a QR code on the SDS you are using linking back to this website then you did not get the SDS from the author and Copyright Holder.  Dr. David V. Sheehan is the Copyright Holder, Trademark Holder, and author of the SDS in all languages.  This copyright for the SDS has been registered with the US Copyright Office.

The cost of licensing the SDS is $4 USD for each use, i.e. each administration to a subject and/or each use in training.

Note: Non-profit institutions sometimes incorrectly assume that the license fee does not apply because they are “not-for-profit”. The licensing fee applies to all uses.

The license and license fee applies to all uses.

Dr. Sheehan licenses the SDS in paper format for distribution as follows: (1) in paper form for any uses, or (2) in fixed-pdf form, paper form, or both for use in clinical or academic research trials or studies.

Many patients suffer impairment of functioning at work, at school, in social settings or at home above and beyond their symptoms.  Insurance companies, employers, government agencies, clinicians and drug companies seeking regulatory approval want to be assured that treatment not only improves symptoms but also restores functioning. The SDS can be used:

  • To assess and monitor the severity of functional impairment over time and in response to treatment in primary care as well as mental health settings.
  • To identify and track disability and functional impairment as an efficacy outcome measure, adverse event and/or treatment emergent effect in clinical trials and treatment outcome studies.
  • To provide documentation of disability and impairment in detailed forensic evaluations.
  • To detect and describe the incidence or prevalence and severity of disability and impairment in population research including national and international epidemiology studies and community surveys.

The SDS is unique in using a discretized analog (Discan) metric that subjects with different cognitive orientations (verbal, numeric, and visual spatial) can easily follow. Some people rate numerically (”he was 6’3” tall”), others use verbal descriptors (“he was very tall”), and still others communicate by rating space visually (using their hands to point while commenting “he was this tall”). Some choose a combination of two or all three methods. For each of its functional domains (work / social / family life), the SDS allows subjects to simultaneously anchor their perceptions of their own impairment all three ways (verbally, numerically and visually-spatially). It also allows enough points of discrimination so that subjects can make fine distinctions in degrees of impairment. This format makes the SDS uniquely sensitive to efficacy signals in treatment studies. Additionally, the SDS contains two numeric measures for “days lost” and “days underproductive” that can be used to assess the impact of disability on work and productivity.

Typically, the SDS takes 1-2 minutes to administer.

No minimum qualification is needed to administer the SDS. However, in research settings where precision is required, training in the use of the SDS is recommended. For more information about training, CLICK HERE.

Note:Dr. Sheehan only provides consultation, guidance on regulatory agency questions, and training to those who license the Sheehan Disability Scale (SDS directly from him. Contact Dr. Sheehan at davidVsheehan@gmail.com for additional information.  If you do not see a QR code on the Sheehan Disability Scale (SDS) you are using linking back to this website, then you did not get the Sheehan Disability Scale (SDS) from the author and Copyright Holder.  Dr. David V. Sheehan is the Copyright Holder, Trademark Holder and author of the Sheehan Disability Scale (SDS) in all languages.  This copyright for the SDS has been registered with the US Copyright Office.

Yes. Dr. Sheehan’s license allows you to administer the SDS remotely as long as you complete the interview on paper as a primary source document. It is up to your protocol to determine how appropriate remote administration is for your patient population. For best results, Dr. Sheehan’s recommendation is to conduct the interview using video, such as Zoom or Skype, rather than phone. The SDS can be rated by patient or clinician. Because of this flexibility it is useful for inpatients as well as outpatients and can also be used in community and population studies.

If you are doing research, you should also review other applicable rules to make sure that remote administration is acceptable to any agency, such as the FDA, who may have oversight of your research.

The standard version of the SDS for adults meets most needs, most of the time in clinical and research settings. The pediatric version (SDS-P) is useful for children since it can be parent or clinician rated for children over the age of 6-11. We recommend the adolescent version (SDS-A) for adolescents age 12-17 since it can be either self-rated or clinician rated.

The SDS can be rated by patient or clinician. Because of this flexibility it is useful for inpatients as well as outpatients and can also be used in community and population studies. Clinician input and judgment are always recommended with making any assessment. 

Yes. Please CLICK HERE for a watermarked preview copy for review only or contact Dr. Sheehan at davidVsheehan@gmail.com.

Yes, Dr. Sheehan can design a customized version of the SDS to meet the needs of a specific study or clinical setting. Contact Dr. Sheehan at davidVsheehan@gmail.com to discuss a customized version.

Requests to access existing non-English translations or for any new translations should be submitted through MAPI Research Trust’s ePROVIDE COA platform at

https://eprovide.mapi-trust.org/ using the following process:

  1. Go to Submit a request
  2. If you haven't registered yet, you'll be asked to sign up for free
  3. Complete the request form. Please attach a copy of the signed and fully executed license agreement signed by Dr. David V Sheehan.

A fully executed license is required for use of the Sheehan-Suicidality Tracking Scale (S-STS) in any language. To license the S-STS directly from Dr. Sheehan, the author and copyright holder, you will need complete his license agreement. Click here to learn more about the S-STS or to download a License for use.

Dr. Sheehan only provides consultation, guidance on regulatory agency questions, and training to those who license the S-STS directly from him. Contact Dr. Sheehan at davidVsheehan@gmail.com for additional information. If you do not see a QR code on the S-STS you are using linking back to this website then you did not get the SDS from the author and Copyright Holder.  Dr. David V. Sheehan is the Copyright Holder, Trademark Holder, and author of the S-STS in all languages.  This copyright for the S-STS has been registered with the US Copyright Office.

CLICK HERE for more information about Sheehan Scales.

The cost of licensing the S-STS is $4 USD for each use, i.e. each administration to a subject and/or each use in training.

Note: Non-profit institutions sometimes incorrectly assume that the license fee does not apply because they are “not-for-profit”. The licensing fee applies to all uses.

The license and license fee applies to all uses.

Dr. Sheehan licenses the S-STS in paper format for distribution as follows: (1) in paper form for any uses, or (2) in fixed-pdf form, paper form, or both for use in clinical or academic research trials or studies.

The S-STS can be used as a systematic means:

  • To assess and monitor suicidality in primary care as well as mental health settings (inpatient and outpatient).
  • To identify and track suicidality as an efficacy outcome measure, adverse event, and/or treatment emergent effect in clinical trials and treatment outcome studies.
  • To provide detailed documentation of suicidality in forensic evaluations.
  • To detect and describe the incidence or prevalence and severity of suicidality in population research including national and international epidemiology studies and community surveys.

The S-STS is unique in the following ways:

  • The S-STS asks about a broader range of suicidality phenomena than other suicidality scales. For example, beyond suicidal ideation and behavior, it has questions about suicidal impulses, suicidal hallucinations, delusional suicidality, and suicidal dreams.
  • Unlike its most used alternative, the C-SSRS, which uses a binary (Yes/No) response format, confirming the presence or absence of suicidality, the S-STS uses a numeric Likert format. A benefit of this format is that it allows raters to make fine distinctions in the seriousness of suicidality symptoms and track changes over time. Also, item and cluster scores can be graphed quantitatively.
  • The S-STS can be mapped closely to FDA classification categories of suicidality.
  • In clinical trials the S-STS has been found to be uniquely sensitive in detecting drug-placebo differences and treatment effects.
  • To our knowledge, the S-STS is the only suicidal assessment scale that has been linguistically validated for children and adolescents.

No minimum qualification is needed to administer the S-STS. What is more critical is that raters be comfortable discussing suicidality with patients and nonjudgment in their approach to suicidality. However, in research settings where precision is required, we do advise training in the use of the S-STS.

This is to ensure that the S-STS is administered and interpreted correctly and to reduce the risk of false positives or false negatives. We leave the final decision of selection and credentialing of raters up to the local sites.

Note: Dr. Sheehan only provides consultation, guidance on regulatory agency questions, and training to those who license the Sheehan-Suicidality Tracking Scale (S-STS) directly from him. Contact Dr. Sheehan at davidVsheehan@gmail.com for additional information.  If you do not see a QR code on the Sheehan-Suicidality Tracking Scale (S-STS) you are using linking back to this website, then you did not get the Sheehan-Suicidality Tracking Scale (S-STS) from the author and Copyright Holder.  Dr. David V. Sheehan is the Copyright Holder, Trademark Holder and author of the Sheehan-Suicidality Tracking Scale (S-STS) in all languages.  This copyright for the S-STS has been registered with the US Copyright Office.

Yes. Dr. Sheehan’s license allows you to administer the S-STS remotely as long as you complete the S-STS on paper as a primary source document. It is up to your protocol to determine how appropriate remote administration is for your patient population. Be sure to review HIPAA and GDPR privacy rules. If you are doing research, you should also review other applicable rules to make sure that remote administration is acceptable to any agency, such as the FDA, who may have oversight of your research.

The standard version of the S-STS for adults meets most needs, most of the time in clinical and research settings.

For children and adolescents, the S-STS is available in 3 age-related, linguistically validated versions (for 6 to 8 year olds, 9 to 10 year olds, and 13 to 17 year olds). The pediatric version (S-STS-P) is useful for all three age groups since it can be parent or clinician rated. We recommend the adolescent version (S-STS-A) for adolescents aged 13-17 since it can be either self-rated by the adolescent or clinician rated.

The average time to administer the S-STS is 8.4 minutes. This administration time is comparable to that for the C-SSRS (8.1 minutes) and shorter than that that for the ISST-Plus (14.5 min).

The S-STS can be patient or clinician rated but should always be clinician reviewed, preferably by someone with clinical mental health experience and training. To ensure that the S-STS is rated and interpreted correctly and to reduce the risk of false positives or false negatives, we recommend training in the use of the S-STS. For more information about training, CLICK HERE.

Yes. Please CLICK HERE for a watermarked preview copy for review only or contact Dr. Sheehan at davidVsheehan@gmail.com.

CLICK HERE for more information about Sheehan Scales.

Yes, Dr. Sheehan can design a customized version of the S-STS to meet the needs of a specific study or clinical setting. Contact Dr. Sheehan at davidVsheehan@gmail.com to discuss a customized version.

Requests to access existing non-English translations or for any new translations should be submitted through MAPI Research Trust’s ePROVIDE COA platform at

https://eprovide.mapi-trust.org/ using the following process:

  1. Go to Submit a request
  2. If you haven't registered yet, you'll be asked to sign up for free
  3. Complete the request form. Please attach a copy of the signed and fully executed license agreement signed by Dr. David V Sheehan.

Best Sellers